Trials / Completed
CompletedNCT03503877
Media, Morphokinetics, and Mosaicism
Aneuploidy Rates and Morphokinetic Parameters in Sibling Embryos Cultured in Distinct Culture Media
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- University of California, San Francisco · Academic / Other
- Sex
- Female
- Age
- 18 Years – 42 Years
- Healthy volunteers
- Accepted
Summary
Embryonic aneuploidy is the underlying etiology for the majority of failed implantation and miscarriage. Preimplantation genetic screening (PGS) with transfer of a euploid embryo has been advocated as a strategy for increasing live birth rates with a single embryo transfer. Culturing embryos to the blastocyst stage for trophectoderm biopsy is a requirement for PGS. Several commercially-available single-step embryonic culture media with varying composition have been established for use in the IVF laboratory. Early reports have suggested differences in clinical outcomes, such as aneuploidy and miscarriage rates, with distinct culture media currently in standard use. However, there have been no clinical trials demonstrating the superiority of any one commercially-available culture media formulation. As a result, clinics use media with varying composition based upon familiarity and cost.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | EmbryoScope Plus | All embryos will be cultured in the EmbryoScope Plus to obtain morphokinetic data |
| OTHER | GLOBAL MEDIA | Embryos will be cultured in GLOBAL media |
| OTHER | SAGE MEDIA | Embryos will be cultured in SAGE media |
Timeline
- Start date
- 2018-02-14
- Primary completion
- 2019-11-28
- Completion
- 2019-11-28
- First posted
- 2018-04-20
- Last updated
- 2022-12-14
- Results posted
- 2022-12-14
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03503877. Inclusion in this directory is not an endorsement.